"Biden Administration Intentionally Downplayed Myocarditis Risk Following Covid Jab"

A newly released report from the U.S. Senate Permanent Subcommittee on Investigations confirms what many have understood for years. Under the Biden administration, federal health agencies failed to promptly and transparently warn the American public about the very real myocarditis risks linked to the experimental mRNA COVID-19 jabs, despite early evidence from Israel and VAERS data highlighting the dangers. In other words—based on newly unredacted documents—health officials were well aware of heart inflammation risks as a result of the mRNA shots. But instead of promptly alerting the public, which is their duty, they chose to stay tight-lipped on the results and downplay the risks. The report declared:

“Specifically, in May 2021, following months of reports of myocarditis after COVID-19 vaccination, health officials at HHS discussed whether to issue a formal warning about the adverse event. The formal warning about myocarditis was initially going to be distributed nationwide as a Health Alert Network (“HAN”) message, which, according to the Centers for Disease Control and Prevention’s (“CDC”) website, is “CDC’s primary method of sharing cleared information about urgent public health incidents with public information officers; federal, state, territorial, tribal, and local public health practitioners; clinicians; and public health laboratories.”

Health officials at the CDC and the Food and Drug Administration (“FDA”) ultimately decided against issuing a formal HAN and, instead, posted “clinical considerations” on the CDC’s website about myocarditis.”

The report, titled “Failure to Warn: How Federal Health Agencies Downplayed the Risk of Myocarditis and Other Adverse Events Following COVID-19 Vaccination,” was released on Wednesday, May 21, 2025, by Sen. Ron Johnson, R-Wis. The 55-page PDF accused the Department of Health and Human Services (HHS), the Centers for Disease Control and Prevention (CDC), and the Food and Drug Administration (FDA)—under the supervision of the Biden administration—of delaying and soft-pedaling warnings about myocarditis risks, potentially endangering the public health of millions of individuals living in the United States.